Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9B5L9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 248 | 252 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.716 |
CLV_NRD_NRD_1 | 310 | 312 | PF00675 | 0.603 |
CLV_NRD_NRD_1 | 341 | 343 | PF00675 | 0.444 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.571 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.324 |
CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.599 |
CLV_PCSK_PC1ET2_1 | 209 | 211 | PF00082 | 0.662 |
CLV_PCSK_PC1ET2_1 | 260 | 262 | PF00082 | 0.324 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.679 |
CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.333 |
DEG_SCF_FBW7_1 | 114 | 120 | PF00400 | 0.479 |
DEG_SCF_FBW7_2 | 148 | 155 | PF00400 | 0.477 |
DEG_SPOP_SBC_1 | 217 | 221 | PF00917 | 0.619 |
DOC_CKS1_1 | 114 | 119 | PF01111 | 0.749 |
DOC_CKS1_1 | 201 | 206 | PF01111 | 0.489 |
DOC_CKS1_1 | 281 | 286 | PF01111 | 0.519 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 34 | 43 | PF00134 | 0.430 |
DOC_CYCLIN_yCln2_LP_2 | 39 | 45 | PF00134 | 0.430 |
DOC_MAPK_gen_1 | 11 | 19 | PF00069 | 0.461 |
DOC_MAPK_gen_1 | 129 | 139 | PF00069 | 0.722 |
DOC_MAPK_gen_1 | 287 | 295 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 297 | 304 | PF00069 | 0.569 |
DOC_MAPK_MEF2A_6 | 77 | 84 | PF00069 | 0.349 |
DOC_PP1_RVXF_1 | 95 | 101 | PF00149 | 0.398 |
DOC_PP1_SILK_1 | 399 | 404 | PF00149 | 0.473 |
DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.595 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.758 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.698 |
DOC_USP7_MATH_1 | 300 | 304 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 358 | 362 | PF00917 | 0.448 |
DOC_USP7_MATH_2 | 30 | 36 | PF00917 | 0.433 |
DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.622 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.555 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.701 |
DOC_WW_Pin1_4 | 190 | 195 | PF00397 | 0.779 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.653 |
DOC_WW_Pin1_4 | 280 | 285 | PF00397 | 0.462 |
DOC_WW_Pin1_4 | 343 | 348 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.345 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.414 |
LIG_14-3-3_CanoR_1 | 132 | 140 | PF00244 | 0.649 |
LIG_14-3-3_CanoR_1 | 26 | 30 | PF00244 | 0.384 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.550 |
LIG_BIR_III_2 | 344 | 348 | PF00653 | 0.507 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.710 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.727 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.488 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.508 |
LIG_FHA_2 | 107 | 113 | PF00498 | 0.557 |
LIG_FHA_2 | 209 | 215 | PF00498 | 0.683 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.552 |
LIG_FHA_2 | 310 | 316 | PF00498 | 0.384 |
LIG_FHA_2 | 330 | 336 | PF00498 | 0.406 |
LIG_LIR_Gen_1 | 106 | 115 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 3 | 10 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 35 | 44 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 395 | 406 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 106 | 110 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 3 | 9 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 35 | 39 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 395 | 401 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 72 | 76 | PF02991 | 0.346 |
LIG_MYND_3 | 167 | 171 | PF01753 | 0.425 |
LIG_Rb_pABgroove_1 | 392 | 400 | PF01858 | 0.490 |
LIG_SH2_CRK | 398 | 402 | PF00017 | 0.362 |
LIG_SH2_CRK | 6 | 10 | PF00017 | 0.421 |
LIG_SH2_NCK_1 | 331 | 335 | PF00017 | 0.427 |
LIG_SH2_NCK_1 | 6 | 10 | PF00017 | 0.466 |
LIG_SH2_STAP1 | 398 | 402 | PF00017 | 0.352 |
LIG_SH2_STAP1 | 6 | 10 | PF00017 | 0.463 |
LIG_SH2_STAT3 | 15 | 18 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.641 |
LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.520 |
LIG_SH2_STAT5 | 331 | 334 | PF00017 | 0.443 |
LIG_SH3_1 | 198 | 204 | PF00018 | 0.738 |
LIG_SH3_2 | 201 | 206 | PF14604 | 0.701 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.725 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.721 |
LIG_SH3_3 | 278 | 284 | PF00018 | 0.464 |
LIG_SUMO_SIM_par_1 | 277 | 283 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 300 | 305 | PF11976 | 0.552 |
LIG_SUMO_SIM_par_1 | 320 | 327 | PF11976 | 0.245 |
LIG_TRFH_1 | 90 | 94 | PF08558 | 0.350 |
LIG_TYR_ITSM | 2 | 9 | PF00017 | 0.509 |
LIG_WRC_WIRS_1 | 104 | 109 | PF05994 | 0.445 |
MOD_CDC14_SPxK_1 | 126 | 129 | PF00782 | 0.480 |
MOD_CDK_SPK_2 | 285 | 290 | PF00069 | 0.461 |
MOD_CDK_SPxK_1 | 123 | 129 | PF00069 | 0.540 |
MOD_CDK_SPxK_1 | 148 | 154 | PF00069 | 0.725 |
MOD_CDK_SPxK_1 | 190 | 196 | PF00069 | 0.789 |
MOD_CDK_SPxK_1 | 200 | 206 | PF00069 | 0.586 |
MOD_CDK_SPxxK_3 | 280 | 287 | PF00069 | 0.466 |
MOD_CDK_SPxxK_3 | 90 | 97 | PF00069 | 0.430 |
MOD_CK1_1 | 323 | 329 | PF00069 | 0.326 |
MOD_CK1_1 | 360 | 366 | PF00069 | 0.515 |
MOD_CK2_1 | 106 | 112 | PF00069 | 0.553 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.647 |
MOD_CK2_1 | 329 | 335 | PF00069 | 0.445 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.534 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.458 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.671 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.180 |
MOD_GlcNHglycan | 373 | 376 | PF01048 | 0.546 |
MOD_GlcNHglycan | 406 | 409 | PF01048 | 0.438 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.541 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.529 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.666 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.630 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.688 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.477 |
MOD_GSK3_1 | 245 | 252 | PF00069 | 0.414 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.457 |
MOD_GSK3_1 | 358 | 365 | PF00069 | 0.472 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.309 |
MOD_N-GLC_1 | 148 | 153 | PF02516 | 0.683 |
MOD_N-GLC_1 | 66 | 71 | PF02516 | 0.311 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.500 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.664 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.701 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.734 |
MOD_NEK2_1 | 397 | 402 | PF00069 | 0.456 |
MOD_NEK2_2 | 218 | 223 | PF00069 | 0.757 |
MOD_PK_1 | 362 | 368 | PF00069 | 0.498 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.707 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.794 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.430 |
MOD_PKA_2 | 309 | 315 | PF00069 | 0.313 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.335 |
MOD_Plk_4 | 397 | 403 | PF00069 | 0.419 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.325 |
MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.626 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.556 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.707 |
MOD_ProDKin_1 | 190 | 196 | PF00069 | 0.781 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.655 |
MOD_ProDKin_1 | 280 | 286 | PF00069 | 0.462 |
MOD_ProDKin_1 | 343 | 349 | PF00069 | 0.488 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.345 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.414 |
TRG_DiLeu_BaEn_2 | 31 | 37 | PF01217 | 0.430 |
TRG_DiLeu_BaEn_4 | 171 | 177 | PF01217 | 0.472 |
TRG_DiLeu_BaLyEn_6 | 344 | 349 | PF01217 | 0.495 |
TRG_ENDOCYTIC_2 | 398 | 401 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.365 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.385 |
TRG_NLS_Bipartite_1 | 191 | 213 | PF00514 | 0.727 |
TRG_NLS_MonoExtC_3 | 208 | 214 | PF00514 | 0.648 |
TRG_NLS_MonoExtN_4 | 206 | 213 | PF00514 | 0.656 |
TRG_Pf-PMV_PEXEL_1 | 154 | 159 | PF00026 | 0.687 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILS6 | Leptomonas seymouri | 59% | 96% |
A0A0S4IL96 | Bodo saltans | 30% | 86% |
A0A3R7KTI0 | Trypanosoma rangeli | 37% | 100% |
A0A3S7X8R1 | Leishmania donovani | 88% | 100% |
A4HBE7 | Leishmania braziliensis | 79% | 100% |
A4IAJ5 | Leishmania infantum | 88% | 100% |
C9ZLP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 95% |
Q4Q2B7 | Leishmania major | 89% | 100% |
V5BW13 | Trypanosoma cruzi | 38% | 100% |